Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
批准号:
10497751
负责人:
Julie E. Ledgerwood
金额:
$398.26万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ClinicalClinical TrialsCommunicable DiseasesConeDrug KineticsEbola Hemorrhagic FeverEbola virusEmerging Communicable DiseasesEvaluationGlycoproteinsInfectious Diseases ResearchMalariaMalaria preventionMonoclonal AntibodiesPhasePublishingRandomized Controlled TrialsResearch Project GrantsSafetyTherapeuticTherapeutic Monoclonal AntibodiesVaccine ResearchVirusWalkersWritingbiodefenseclinical centerimmunogenicitynovel strategiesopen labelpathogenphase 1 studyprogramsresearch clinical testing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Vaccine Research Center (VRC) Monoclonal Antibody Studies in Biodefense and Emerging Infectious Diseases research project is aimed at the clinical evaluation of monoclonal antibody (mAb) products related to infectious disease pathogens. Current targets include Ebola virus disease and malaria. Further evaluation will continue as the VRC develops additional monoclonal anitbody products aimed at emerging infectious disease targets.
Published results on clinical products and trials include:
VRC 608:
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M, Sitar S, Yamshchikov G, Berkowitz N, Andrews C, Vazquez S, Laurencot C, Misasi J, Arnold F, Carlton K, Lawlor H, Gall J, Bailer RT, McDermott A, Capparelli E, Koup RA, Mascola JR, Graham BS, Sullivan NJ, Ledgerwood JE; VRC 608 Study team. Lancet. 2019 Mar 2;393(10174):889-898.
PALM Study:
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ; PALM Writing Group, Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Valle D, Nordwall J; PALM Consortium Study Team. N Engl J Med. 2019 Dec 12;381(24):2293-2303.
VRC 612:
A Monoclonal Antibody for Malaria Prevention. Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, Gordon IJ, Plummer SH, Trofymenko O, Hu Z, Campos Chagas A, O'Connell S, Basappa M, Douek N, Narpala SR, Barry CR, Widge AT, Hicks R, Awan SF, Wu RL, Hickman S, Wycuff D, Stein JA, Case C, Evans BP, Carlton K, Gall JG, Vazquez S, Flach B, Chen GL, Francica JR, Flynn BJ, Kisalu NK, Capparelli EV, McDermott A, Mascola JR, Ledgerwood JE, Seder RA; VRC 612 Study Team.
N Engl J Med. 2021 Aug 11.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biodefense and Emerging Infectious Disease Vaccine Studies
-
批准号:10275373
-
项目类别:
-
资助金额:$422.89万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:8946585
-
项目类别:
-
资助金额:$50.97万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:9562819
-
项目类别:
-
资助金额:$180.15万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:10275372
-
项目类别:
-
资助金额:$181.11万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
HIV Monoclonal Antibody Studies
-
批准号:10273010
-
项目类别:
-
资助金额:$503.49万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
HIV Vaccine Studies
-
批准号:10497733
-
项目类别:
-
资助金额:$630.05万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
HIV Monoclonal Antibody Studies
-
批准号:10497736
-
项目类别:
-
资助金额:$511.39万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
HIV Preventive Vaccine and Monoclonal Antibody Studies
-
批准号:8946584
-
项目类别:
-
资助金额:$521.1万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
-
批准号:9353052
-
项目类别:
-
资助金额:$107.47万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
COVID-19 Sample Collection and Vaccine Studies
-
批准号:10497765
-
项目类别:
-
资助金额:$48.59万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
-
批准号:10273023
-
项目类别:
-
资助金额:$342.3万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
-
批准号:9562821
-
项目类别:
-
资助金额:$213.25万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Biodefense/Emerging Infection Vaccine Studies
-
批准号:9353051
-
项目类别:
-
资助金额:$226.6万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:9353050
-
项目类别:
-
资助金额:$100.97万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
COVID-19 Sample Collection and Vaccine Studies
-
批准号:10275375
-
项目类别:
-
资助金额:$59.28万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
-
批准号:9161763
-
项目类别:
-
资助金额:$77.47万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Biodefense/Emerging Infection Vaccine Studies
-
批准号:9562820
-
项目类别:
-
资助金额:$467.47万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Biodefense and Emerging Infectious Disease Vaccine Studies
-
批准号:10018374
-
项目类别:
-
资助金额:$496.28万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:10018373
-
项目类别:
-
资助金额:$82.71万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
Sample Collection and General Screening Protocols
-
批准号:10497734
-
项目类别:
-
资助金额:$143.35万
-
财政年份:--
-
负责人:Julie E. Ledgerwood
-
依托单位:
海外基金